Raloxifene Hydrochloride
Product Images NDC 63629-8209

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 63629-8209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636298209)

Raloxifene 60mg tablet label packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates the product is a white oval tablet, with an NDC of 63629-8209-1. It compares to Evista 60mg tablet by Amneal Pharmaceuticals Pvt. Ltd. The label includes storage instructions to keep at room temperature (20°-25°C) and a warning to keep drugs out of reach of children. Expiration date area is marked as MM/YY.*

FDA Label Image

Chemical Structure (Raloxifene HCl Tablets Usp 1)

Chemical structure of raloxifene hydrochloride showing its molecular framework with aromatic rings, hydroxyl groups, thioether linkage, and a chloride ion associated with the protonated amine group.*

FDA Label Image

Image 1 (Raloxifene HCl Tablets Usp 2)

Two line graphs depicting total hip mean percentage change from baseline over 24 months after randomization. The upper graph compares Raloxifene Hydrochloride and placebo groups with percentage change on the y-axis and time in months on the x-axis. The lower graph adds a group receiving conjugated estrogens (CE) along with Raloxifene Hydrochloride and placebo for hysterectomized women, showing percentage change trends over the same period. Both graphs include error bars and notes about the analysis method.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.